ID   M4K1_HUMAN              Reviewed;         833 AA.
AC   Q92918;
DT   28-MAR-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1997, sequence version 1.
DT   15-MAR-2017, entry version 163.
DE   RecName: Full=Mitogen-activated protein kinase kinase kinase kinase 1;
DE            EC=2.7.11.1;
DE   AltName: Full=Hematopoietic progenitor kinase;
DE   AltName: Full=MAPK/ERK kinase kinase kinase 1;
DE            Short=MEK kinase kinase 1;
DE            Short=MEKKK 1;
GN   Name=MAP4K1; Synonyms=HPK1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000312|EMBL:AAB97983.1};
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY,
RP   AND INTERACTION WITH MAP3K1.
RC   TISSUE=Fetal liver;
RX   PubMed=8824585; DOI=10.1101/gad.10.18.2251;
RA   Hu M.C.-T., Qiu W.R., Wang X., Meyer C.F., Tan T.-H.;
RT   "Human HPK1, a novel human hematopoietic progenitor kinase that
RT   activates the JNK/SAPK kinase cascade.";
RL   Genes Dev. 10:2251-2264(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-421 AND SER-586, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-405; SER-407; SER-413
RP   AND SER-421, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [6]
RP   VARIANTS [LARGE SCALE ANALYSIS] THR-312; SER-351; LEU-361 AND PHE-737.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [7]
RP   FUNCTION, PHOSPHORYLATION AT THR-165; SER-171; THR-175 AND THR-355,
RP   UBIQUITINATION, MUTAGENESIS OF THR-355, AND INTERACTION WITH FBXW8.
RX   PubMed=24362026; DOI=10.1074/jbc.M113.520106;
RA   Wang H., Chen Y., Lin P., Li L., Zhou G., Liu G., Logsdon C., Jin J.,
RA   Abbruzzese J.L., Tan T.H., Wang H.;
RT   "The CUL7/F-box and WD repeat domain containing 8 (CUL7/Fbxw8)
RT   ubiquitin ligase promotes degradation of hematopoietic progenitor
RT   kinase 1.";
RL   J. Biol. Chem. 289:4009-4017(2014).
CC   -!- FUNCTION: Serine/threonine-protein kinase, which may play a role
CC       in the response to environmental stress. Appears to act upstream
CC       of the JUN N-terminal pathway. May play a role in hematopoietic
CC       lineage decisions and growth regulation. Able to
CC       autophosphorylate. {ECO:0000269|PubMed:24362026,
CC       ECO:0000269|PubMed:8824585}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC       {ECO:0000269|PubMed:8824585}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:8824585};
CC   -!- SUBUNIT: Interacts with MAP3K1. Interacts with FBXW8.
CC       {ECO:0000269|PubMed:24362026, ECO:0000269|PubMed:8824585}.
CC   -!- INTERACTION:
CC       P00519:ABL1; NbExp=3; IntAct=EBI-881, EBI-375543;
CC       P46108:CRK; NbExp=3; IntAct=EBI-881, EBI-886;
CC       P46109:CRKL; NbExp=5; IntAct=EBI-881, EBI-910;
CC       P06241:FYN; NbExp=2; IntAct=EBI-881, EBI-515315;
CC       P62993:GRB2; NbExp=8; IntAct=EBI-881, EBI-401755;
CC       P16333:NCK1; NbExp=4; IntAct=EBI-881, EBI-389883;
CC       P27986:PIK3R1; NbExp=2; IntAct=EBI-881, EBI-79464;
CC       P19174:PLCG1; NbExp=6; IntAct=EBI-881, EBI-79387;
CC       Q13291:SLAMF1; NbExp=3; IntAct=EBI-881, EBI-4315002;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q92918-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q92918-2; Sequence=VSP_040340;
CC   -!- TISSUE SPECIFICITY: Expressed primarily in hematopoietic organs,
CC       including bone marrow, spleen and thymus. Also expressed at very
CC       low levels in lung, kidney, mammary glands and small intestine.
CC       {ECO:0000269|PubMed:8824585}.
CC   -!- PTM: Autophosphorylates: phosphorylation promotes ubiquitination
CC       by the Cul7-RING(FBXW8) ubiquitin-protein ligase complex, leading
CC       to its degradation by the proteasome.
CC       {ECO:0000269|PubMed:24362026}.
CC   -!- PTM: Ubiquitinated by the Cul7-RING(FBXW8) ubiquitin-protein
CC       ligase complex following autophosphorylation, leading to its
CC       degradation by the proteasome. {ECO:0000269|PubMed:24362026}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. STE20 subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U66464; AAB97983.1; -; mRNA.
DR   EMBL; AC005933; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC008649; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS42564.1; -. [Q92918-2]
DR   CCDS; CCDS59385.1; -. [Q92918-1]
DR   RefSeq; NP_001036065.1; NM_001042600.2. [Q92918-2]
DR   RefSeq; NP_009112.1; NM_007181.5. [Q92918-1]
DR   UniGene; Hs.95424; -.
DR   ProteinModelPortal; Q92918; -.
DR   SMR; Q92918; -.
DR   BioGrid; 116354; 25.
DR   DIP; DIP-31019N; -.
DR   IntAct; Q92918; 18.
DR   MINT; MINT-1176198; -.
DR   STRING; 9606.ENSP00000380066; -.
DR   BindingDB; Q92918; -.
DR   ChEMBL; CHEMBL5749; -.
DR   GuidetoPHARMACOLOGY; 2085; -.
DR   iPTMnet; Q92918; -.
DR   PhosphoSitePlus; Q92918; -.
DR   DMDM; 29427916; -.
DR   MaxQB; Q92918; -.
DR   PaxDb; Q92918; -.
DR   PeptideAtlas; Q92918; -.
DR   PRIDE; Q92918; -.
DR   DNASU; 11184; -.
DR   Ensembl; ENST00000396857; ENSP00000380066; ENSG00000104814. [Q92918-2]
DR   Ensembl; ENST00000591517; ENSP00000465039; ENSG00000104814. [Q92918-1]
DR   Ensembl; ENST00000634395; ENSP00000489001; ENSG00000282928. [Q92918-1]
DR   Ensembl; ENST00000634494; ENSP00000489158; ENSG00000282928. [Q92918-2]
DR   GeneID; 11184; -.
DR   KEGG; hsa:11184; -.
DR   UCSC; uc002oix.3; human. [Q92918-1]
DR   CTD; 11184; -.
DR   DisGeNET; 11184; -.
DR   GeneCards; MAP4K1; -.
DR   HGNC; HGNC:6863; MAP4K1.
DR   HPA; CAB007754; -.
DR   HPA; HPA007419; -.
DR   MIM; 601983; gene.
DR   neXtProt; NX_Q92918; -.
DR   OpenTargets; ENSG00000104814; -.
DR   PharmGKB; PA30609; -.
DR   eggNOG; KOG0576; Eukaryota.
DR   eggNOG; ENOG410XP9G; LUCA.
DR   GeneTree; ENSGT00810000125351; -.
DR   HOGENOM; HOG000230824; -.
DR   HOVERGEN; HBG036702; -.
DR   InParanoid; Q92918; -.
DR   KO; K04408; -.
DR   OMA; EMSTEHR; -.
DR   OrthoDB; EOG091G022R; -.
DR   PhylomeDB; Q92918; -.
DR   TreeFam; TF105121; -.
DR   SignaLink; Q92918; -.
DR   SIGNOR; Q92918; -.
DR   GeneWiki; MAP4K1; -.
DR   GenomeRNAi; 11184; -.
DR   PMAP-CutDB; Q92918; -.
DR   PRO; PR:Q92918; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000104814; -.
DR   CleanEx; HS_MAP4K1; -.
DR   ExpressionAtlas; Q92918; baseline and differential.
DR   Genevisible; Q92918; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0008349; F:MAP kinase kinase kinase kinase activity; IDA:UniProtKB.
DR   GO; GO:0004672; F:protein kinase activity; TAS:ProtInc.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0007257; P:activation of JUN kinase activity; TAS:ProtInc.
DR   GO; GO:0000185; P:activation of MAPKKK activity; IC:UniProtKB.
DR   GO; GO:0008283; P:cell proliferation; IMP:UniProtKB.
DR   GO; GO:0035556; P:intracellular signal transduction; IDA:UniProtKB.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IDA:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0006950; P:response to stress; IDA:UniProtKB.
DR   InterPro; IPR001180; CNH_dom.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR021160; MAPKKKK.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   Pfam; PF00780; CNH; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   PIRSF; PIRSF038172; MAPKKKK; 1.
DR   SMART; SM00036; CNH; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 2.
DR   PROSITE; PS50219; CNH; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Complete proteome; Kinase;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase; Ubl conjugation.
FT   CHAIN         1    833       Mitogen-activated protein kinase kinase
FT                                kinase kinase 1.
FT                                /FTId=PRO_0000086273.
FT   DOMAIN       17    274       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   DOMAIN      495    800       CNH. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00795}.
FT   NP_BIND      23     31       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    137    137       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   BINDING      46     46       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     165    165       Phosphothreonine; by autocatalysis.
FT                                {ECO:0000269|PubMed:24362026}.
FT   MOD_RES     171    171       Phosphoserine; by autocatalysis.
FT                                {ECO:0000269|PubMed:24362026}.
FT   MOD_RES     175    175       Phosphothreonine; by autocatalysis.
FT                                {ECO:0000269|PubMed:24362026}.
FT   MOD_RES     355    355       Phosphothreonine; by autocatalysis.
FT                                {ECO:0000269|PubMed:24362026}.
FT   MOD_RES     374    374       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P70218}.
FT   MOD_RES     376    376       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P70218}.
FT   MOD_RES     405    405       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     407    407       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     413    413       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     421    421       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:19690332}.
FT   MOD_RES     586    586       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   VAR_SEQ     800    833       LECSGTISPHCNLLLPGSSNSPASASRVAGITGL -> PVV
FT                                VETRPVDDPTAPSNLYIQE (in isoform 2).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_040340.
FT   VARIANT     312    312       P -> T (in dbSNP:rs55924696).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040739.
FT   VARIANT     351    351       P -> S (in dbSNP:rs34591617).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040740.
FT   VARIANT     361    361       P -> L (in dbSNP:rs56060067).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040741.
FT   VARIANT     737    737       S -> F (in a metastatic melanoma sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040742.
FT   VARIANT     811    811       N -> S (in dbSNP:rs12975825).
FT                                /FTId=VAR_051643.
FT   MUTAGEN     355    355       T->A: Retains kinase activity. Not
FT                                degraded by the Cul7-RING ubiquitin-
FT                                protein ligase complex containing FBXW8.
FT                                {ECO:0000269|PubMed:24362026}.
SQ   SEQUENCE   833 AA;  91296 MW;  3C98CF01BE42E151 CRC64;
     MDVVDPDIFN RDPRDHYDLL QRLGGGTYGE VFKARDKVSG DLVALKMVKM EPDDDVSTLQ
     KEILILKTCR HANIVAYHGS YLWLQKLWIC MEFCGAGSLQ DIYQVTGSLS ELQISYVCRE
     VLQGLAYLHS QKKIHRDIKG ANILINDAGE VRLADFGISA QIGATLARRL SFIGTPYWMA
     PEVAAVALKG GYNELCDIWS LGITAIELAE LQPPLFDVHP LRVLFLMTKS GYQPPRLKEK
     GKWSAAFHNF IKVTLTKSPK KRPSATKMLS HQLVSQPGLN RGLILDLLDK LKNPGKGPSI
     GDIEDEEPEL PPAIPRRIRS THRSSSLGIP DADCCRRHME FRKLRGMETR PPANTARLQP
     PRDLRSSSPR KQLSESSDDD YDDVDIPTPA EDTPPPLPPK PKFRSPSDEG PGSMGDDGQL
     SPGVLVRCAS GPPPNSPRPG PPPSTSSPHL TAHSEPSLWN PPSRELDKPP LLPPKKEKMK
     RKGCALLVKL FNGCPLRIHS TAAWTHPSTK DQHLLLGAEE GIFILNRNDQ EATLEMLFPS
     RTTWVYSINN VLMSLSGKTP HLYSHSILGL LERKETRAGN PIAHISPHRL LARKNMVSTK
     IQDTKGCRAC CVAEGASSGG PFLCGALETS VVLLQWYQPM NKFLLVRQVL FPLPTPLSVF
     ALLTGPGSEL PAVCIGVSPG RPGKSVLFHT VRFGALSCWL GEMSTEHRGP VQVTQVEEDM
     VMVLMDGSVK LVTPEGSPVR GLRTPEIPMT EAVEAVAMVG GQLQAFWKHG VQVWALGSDQ
     LLQELRDPTL TFRLLGSPRL ECSGTISPHC NLLLPGSSNS PASASRVAGI TGL
//
